MTOR and cancer: mTOR inhibition became an active area of research to develop and test small inhibitory molecules such as rapamycin analogues -notably RAD001 (Everolimus, Novartis) and CCI-779 (Torisol, Wyeth) to treat diverse diseases, including cancer.